Newsletters

  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
All
  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
R&D InsightY2021

Ways to talk about AMR / Video chat with Maryn McKenna

Dear All, Explaining AMR to our colleagues is not easy! I wrote in a 30 Oct 2019 newsletter about what Wellcome …

Read More >
R&D Insight

G7 Health ministers 3-4 June communique / Implications for choosing wisely

Note: Newsletter now updated to include the communique from the G7 Finance Ministers! Dear All, The G7 met in Oxford …

Read More >
JobsY2021

WHO consultancy: Rollout of Policy Guidance on Integrated Stewardship Activities

Dear All, Just below my signature you will find the full details on a recently posted WHO consultancy opportunity. It’s …

Read More >
R&D InsightY2021

Highly resistant bacterial infections in hospitalized COVID-19 patients: A report from India

Dear All, I was made aware today of this important paper and wanted to share it promptly: Vijay S, Bansal …

Read More >
R&D InsightY2021

MTEC: A funding source for anti-infective projects that (also) have military uses

Dear All, I have recently become aware of MTEC (Medical Technology Enterprise Consortium), a 501(c)(3) nonprofit organization designed to accelerate …

Read More >
JobsY2021

Job openings with WHO and with ICARS (Copenhagen)

Dear All, What a wild day … it feels like the flood gates have opened! I am still smiling about …

Read More >
R&D InsightY2021

From BARDA: 10 more years of AMR funding via an Antibacterial Accelerator!

Dear All, It’s been a busy day! Hot on the heels of today’s Duke-Margolis webinar on combatting AMR during which …

Read More >
JobsY2021

Major Job Opening: Head of the Global AMR R&D Hub Secretariat

Dear All, Launched in 2018, the Global AMR R&D Hub was established following a call from G20 Leaders to address challenges and …

Read More >
IncentivesY2021

Open call to fund an EU-based novel antibacterial to IND

Dear All, GNA NOW (part of the IMI AMR Accelerator; this 25 Mar 2021 press release is a good overview of …

Read More >
R&D InsightY2021

Pull incentives in the EU / Statements by Commissioner Kyriakides

Dear All, Stella Kyriakides, the European Commissioner for Health and Food Safety, made some really interesting statements before the European Parliament’s …

Read More >
IncentivesR&D Insight

Global views: UN Dialogue, WHO @ ECCMID, JPIAMR/JAMRAI (Christine Ardal video)

Dear All, Three global conversations to put on your listen-to-this list! One is this coming week, one is during ECCMID, …

Read More >
JobsY2021

WHO seeks experts for critical antibiotics advisory group

Dear All, WHO have opened a call for experts to be part of an Advisory Group on their Critically Important …

Read More >
R&D InsightY2021

WHO 2020 clinical/preclinical pipeline review; Chat with WHO’s Peter Beyer

Dear All, WHO have today updated their 2019 clinical/preclinical pipeline review by releasing their 2020 analyses of both the clinical …

Read More >
R&D InsightY2021

FDA-NIAID-CDC: Developing drugs for gonorrhea, 23 Apr 21 workshop

Dear All, FDA, NIAID and CDC have announced a public workshop on development considerations of antimicrobial drugs for the treatment …

Read More >
R&D InsightWonkish

Developing antibiotics for children: There are no easy answers

Aside: If you’ve enjoyed the prior discussions of movies to inspire antibiotic R&D and very apropos given the theme of today’s …

Read More >
R&D InsightY2021

Vaccines to turn back the tide of antimicrobial resistance

Dear All, As part of their Immunization Agenda 2030: A Global Strategy to Leave No One Behind, WHO have now …

Read More >
IncentivesR&D Insight

Stewardship & Access Guide from CARB-X, Wellcome, and partners: Analysis, video chat

Dear All, Novel antibacterial agents, vaccines, and diagnostics will do little if they are not widely available and used responsibly. …

Read More >
R&D InsightY2021

Amended Indian PPL slide / SUPERBUGS Act / Novo REPAIR Global Call

Dear All, Three bits of news you can use… First, when I wrote yesterday about the new Indian Priority Pathogen …

Read More >
R&D InsightY2021

Where’s the innovation? / Indian Priority Pathogen List / DTR video explainer

Dear All, Three things briefly this evening: First, the observation about the limited degree of innovation across products in Phases …

Read More >
IncentivesY2021

Pew infographic: Antibiotic R&D needs economic incentives

Dear All, I hope you have been enjoying the excellent new pipeline analysis from Pew Trusts (10 Mar 2021 newsletter) …

Read More >
Scroll to Top